Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
19,159,363
-
Shares change
-
+5,849,074
-
Total reported value, excl. options
-
$223,585,591
-
Value change
-
+$67,245,761
-
Put/Call ratio
-
23.11%
-
Number of buys
-
41
-
Number of sells
-
-18
-
Price
-
$11.67
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q2 2016
82 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q2 2016.
NovoCure Ltd - Common Stock (NVCR) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19,159,363 shares
of 111,111,111 outstanding shares and own 17.24% of the company stock.
Largest 10 shareholders include FMR LLC (4,996,021 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,580,593 shares), VANGUARD GROUP INC (2,357,427 shares), StepStone Group LP (1,815,479 shares), HIGHLINE CAPITAL MANAGEMENT, L.P. (1,755,879 shares), BlackRock Fund Advisors (1,192,298 shares), WELLS FARGO & COMPANY/MN (798,609 shares), STATE STREET CORP (781,171 shares), NORTHERN TRUST CORP (479,666 shares), and BlackRock Institutional Trust Company, N.A. (431,872 shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.